Kindstar Globalgene Technology HK$2.21 billion IPO
We advised Kindstar Global on its IPO and HKEX listing
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Zhenro Properties Group RMB1.3 billion green high-yield notes offering
We advised the initial purchasers on the Regulation S offering of senior notes, issued under Zhenro’s green bond framework
Zylox-Tonbridge Medical Technology HK$2.56 billion IPO
We advised Zylox-Tonbridge Medical Technology on its IPO and HKEX listing
HUTCHMED HK$4.17 billion IPO and primary listing
The shares are listed on the Hong Kong Stock Exchange
Shui On Development $400 million sustainability-linked bonds offering
We advised the joint lead managers on the Regulation S offering
CARsgen Therapeutics HK$3.1 billion IPO
We advised CARsgen Therapeutics on its IPO and HKEX listing
Zhenro Properties Group $340 million high-yield notes offering
We advised the initial purchasers on the Regulation S offering
Zai Lab $857.5 million offering of American depositary shares and ordinary shares
We advised Zai Lab on the concurrent offerings
I-Mab $177 million follow-on secondary offering of ADSs
We advised the underwriters on the equity offering
Akeso HK$1.19 billion share placement
We advised the placing agent in the placement of new shares